Edition:
United States

Unilife Corp (UNS.AX)

UNS.AX on Australia Stock Exchange

0.05AUD
29 Sep 2016
Change (% chg)

-- (--)
Prev Close
$0.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,111,515
52-wk High
$0.38
52-wk Low
$0.05

Summary

Name Age Since Current Position

Mary Wold

62 2016 Non-Executive Chairman of the Board, Lead Independent Director

John Ryan

46 2016 President, Chief Executive Officer, Director

David Hastings

55 2016 Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer

Ian Hanson

42 2016 Chief Operating Officer, Senior Vice President

Stephanie Walters

2016 Senior Vice President, General Counsel, Secretary

Kevin Sellers

2014 Senior Vice President - Marketing and Communications

Richard Beckman

2015 Senior Vice President and Chief Medical Officer

Michael Ratigan

2016 Senior Vice President and Chief Commercial Officer

Molly Weaver

2016 Chief Compliance Officer, Vice President - Quality and Regulatory Affairs

Michael Kamarck

2016 Director

Jeff Carter

57 2009 Non-Executive Director

Harry Hamill

61 2015 Independent Director

William Galle

76 2009 Independent Non-Executive Director

John Lund

49 2009 Independent Non-Executive Director

Biographies

Name Description

Mary Wold

Ms. Mary (Kate) Katherine Wold is Non-Executive Chairman of the Board, Lead Independent Director of the Company. Ms. Wold serves as Chief Executive Officer of the Church Pension Fund, which oversees defined benefit and defined contribution pension plans for clergy and lay employees of the Episcopal Church. Prior to her position at the Church Pension Fund, Ms. Wold served as senior vice president of finance from 2007 to 2009, senior vice president of tax and treasury from 2005 to 2007 and vice president of tax from 2002 to 2005, of Wyeth, a NYSE-listed pharmaceutical company, which was acquired by Pfizer in October 2009. Prior thereto, Ms. Wold spent 17 years with the international law firm of Shearman & Sterling based in New York, specializing in international tax planning for multinational corporations and in the tax aspects of mergers and acquisitions, capital markets and private equity transactions. Ms. Wold received her law degree from the University of Michigan and her Bachelor of Arts degree from Hamline University.

John Ryan

Mr. John Ryan, J.D. is President, Chief Executive Officer, Director of the Company. Mr. Ryan has nearly two decades of legal experience in contract negotiations, corporate compliance, commercial and government litigation, and regulatory matters. Prior to joining Unilife, he was a partner at Duane Morris, one of the 100 largest law firms in the U.S., where he represented healthcare, financial and managed service companies across areas including contract negotiation, dispute resolution, consumer class action litigation and antitrust cases. For eight years, Mr. Ryan held senior roles including Senior Vice President and Deputy General Counsel at Aramark Corporation, a company with a $6 billion market capitalization and $13.5 billion in annual revenue, where he served as Chief Counsel for several business divisions. Mr. Ryan began his legal career as an Assistant District Attorney at the Manhattan District Attorney's Office where he led grand jury investigations and prosecuted white-collar criminals. He is admitted to practice in state and federal courts in Pennsylvania and New York, and is a graduate of Northwestern University School of Law and New York University.

David Hastings

Mr. David Hastings is Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer of the Company. Mr. Hastings most recently served as Chief Financial Officer at Incyte Corporation between 2003 and 2014. Incyte, with a market capitalization of approximately $12.0 billion , is a leading biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs, primarily for oncology. Mr. Hastings played an important role in Incyte's evolution from early stage drug discovery into a financially robust commercial business with an FDA approved oncology drug and a strong clinical pipeline. During his time as CFO Incyte experienced significant increases in revenue and market capitalization. During his 30 year career, including 15 years as a CFO in the biopharmaceutical industry, Mr. Hastings has held senior financial leadership roles at companies such as ArQule, Inc., Genzyme (now a wholly owned subsidiary of Sanofi), and PriceWaterhouseCoopers. He is a Certified Public Accountant (non-active license).

Ian Hanson

Mr. Ian Hanson is Chief Operating Officer, Senior Vice President of the company. Prior to joining Unilife in 2011, Ian previously spent time at Medtronic Diabetes, where he held leadership roles in the development and commercialization of insulin delivery devices and diabetes management systems. Ian holds a B.S. in Mechanical Engineering from California Polytechnic State University and a M.S. in Mechanical Engineering from the University of California at Los Angeles.

Stephanie Walters

Ms. Stephanie Walters is Senior Vice President, General Counsel, Secretary of the Company. She has served as the Company’s Associate General Counsel since 2014.

Kevin Sellers

Mr. Kevin Sellers is Senior Vice President - Marketing and Communications of the Company. Prior to joining Unilife, Sellers spent 23 years at Intel Corporation, a company with a $175B market capitalization and over $52B in annual revenue, in a variety of key marketing, communications and finance functions. For several years at Intel, Sellers served as Vice President of Investor Relations where he was recognized multiple times as the Best IR Professional in his industry by Institutional Investor Magazine and also led Intel to receiving the Best Nasdaq-listed Company for Investor Relations in 2012. Sellers was most recently the Vice President of Creative Services and Digital Marketing where he had responsibility for Intel's global advertising and digital marketing strategy. While in this role, he championed the award-winning 'Look Inside' campaign garnering numerous industry honors including an unprecedented five Cannes Lions Awards for creative excellence. He also led the overhaul of Intel's domain site, Intel.com, elevating it to become one of the top 20 corporate websites in 2013 as listed by Web Globalization Report. Sellers also served in several other strategic roles at Intel including Director of Corporate Brand Strategy and Director of Marketing at Intel Japan based in Tokyo.

Richard Beckman

Dr. Richard L. Beckman , M.D. is Senior Vice President and Chief Medical Officer of Unilife Corporation. Dr. Beckman is a board certified ophthalmologist with thirteen years of clinical practice experience and more than twenty years of corporate executive and consultancy experience with a number of global pharmaceutical, biotech, and medical device companies. Prior to joining Unilife, Dr. Beckman held the position of Chief Medical Officer at Ophthotech Pharmaceuticals, Inc. He also held various leadership roles with Neurotech Pharmaceuticals, Alcon Laboratories, Lux Pharmaceuticals, Becton Dickinson , and Allergan Pharmaceuticals. Dr. Beckman received his medical degree from the University of Michigan , and practiced as a glaucoma specialist for ten years in private practice and three years in academic practice at North Shore University Hospital- Cornell University Medical College, following a Glaucoma Fellowship at Harvard University.

Michael Ratigan

Mr. Michael Ratigan is Senior Vice President and Chief Commercial Officer of the Company. He joined Unilife in 2011 from Becton Dickinson where he was a global commercial leader for Self-Injection Systems and also led commercial efforts for Pre-Filled Syringes in the North American market. Since joining Unilife Mr. Ratigan has led Unilife’s commercial efforts, including the entry into multiple strategic collaborations with leading pharmaceutical and biopharmaceutical companies.

Molly Weaver

Dr. Molly Weaver, Ph.D. is Chief Compliance Officer, Vice President - Quality and Regulatory Affairs of the Company. He has served as Vice President and General Manager since 2011.

Michael Kamarck

Dr. Michael E. Kamarck, Ph.D. is Director of the Company. From 2009 to 2012, Dr. Kamarck served as President of Merck BioVentures and Senior Vice President of Vaccines and Biologics Manufacturing for Merck. From 2001 to 2009, he held various senior executive positions at Wyeth, including President, Technical Operations and Product Supply and was responsible for global technical operations for all of Wyeth’s businesses. Dr. Kamarck also served as a member of the Wyeth Management Committee. Prior to Wyeth, he was employed by Bayer AG for 17 years in a variety of technical and leadership capacities. Dr. Kamarck received his B.A. from Oberlin College and his Ph.D. from the Massachusetts Institute of Technology in Biochemistry, and he was a Leukemia Society Fellow at Yale University.

Jeff Carter

Mr. Jeff Carter serves as an Non-Executive Director of Unilife Corp since November 2009. He has served as a Director of the company since April 2006. From March 2007 to July 2010, Mr. Carter served as company secretary for UMSL. From February 2005 until January 2009, Mr. Carter served as chief financial officer of UMSL. Mr. Carter was a chief financial officer of various publicly listed healthcare companies prior to joining UMSL in February 2005. Prior to entering the healthcare industry Mr. Carter held senior management positions with Coca Cola, Santos, Canadian Imperial Bank of Commerce and Touche Ross. Mr. Carter has in excess of 30 years experience in professional accounting, investment banking, corporate finance and commercial/strategic planning roles. Mr. Carter is a chartered accountant and holds a master’s degree in applied finance from Macquarie University.

Harry Hamill

Mr. Harry Hamill is an Independent Director of the Company. Mr. Hamill has served as an advisor in the life sciences industry since 2010. From 2008 to 2010, Mr. Hamill served as vice president and deputy controller of Wyeth (formerly known as American Home Products Corporation), and held other senior positions at Wyeth from 1992 to 2008, including leading global mergers and acquisitions, vice-president finance for Wyeth’s global manufacturing and distribution operations, and chief financial officer of a global animal health business unit. Wyeth was acquired by Pfizer in October 2009. Prior to his career at Wyeth, Mr. Hamill was a partner with Parente Randolph Orlando Carey and Associates, a regional U.S. accounting firm. Prior to that, Mr. Hamill was a senior audit manager with Arthur Andersen LLP in New York. He is a certified public accountant and a graduate of Bernard M. Baruch College, City University of New York. Our board believes that Mr. Hamill’s experience in finance and accounting and as an executive at a large, global pharmaceutical company with responsibility for, among other things, strategic transactions, financial controls, reporting and planning, and risk management, make him well-suited to serve as a director. He is a Certified Public Accountant and a graduate of Baruch College.

William Galle

Mr. William Galle serves as an Independent Non-Executive Director of Unilife Corp since November 2009. Mr. Galle has been affiliated as an investment banker with Bradley Woods, a 40 year-old New York City-based independent research and investment banking firm specializing in federal regulatory and legislative developments impacting substantial investor portfolios. Since 1993, Mr. Galle has been president of Diversified Portfolio Strategies LLC in Washington D.C., which provides alternative investment advisory services for institutions and substantial investors. Mr. Galle was also an independent director of American Marketing Complex in New York City from October 2007 to December 2009. Prior to his time at Diversified Portfolio Strategies LLC, Mr. Galle was vice president of pension services at Smith Barney, Harris Upham and director of corporate services at NASDAQ in Washington, D.C. Mr. Galle is a graduate of Columbia University, Rutgers University, and the New York Institute of Finance.

John Lund

Mr. John M. Lund serves as an Independent Non-Executive Director of Unilife Corp since November 11, 2009. Since February 2012, Mr. Lund has served as chief financial officer of Reliant Rehabilitation, a private equity backed company, which is a leading provider of long-term care rehabilitation services with over 4,500 US based employees. Mr. Lund has also served as managing partner of Upstart CFO, LLC, a financial consulting company providing CFO advisory services since December 2010, and M&A Holdings, LLC, a private consulting company since July 2003. Mr. Lund was vice president of finance and controller of E-rewards, Inc., an internet market research company from February 2009 to March 2011, and vice president and controller of Nexstar Broadcasting Group, Inc., a NASDAQ listed television broadcasting company during 2008. Prior to that, Mr. Lund held chief financial officer and controller positions for various public and private companies, and was a manager at KPMG LLP, or KPMG. Mr. Lund received the Certificate of Director Education from the National Association of Corporate Directors, or NACD, and completed various corporate governance courses at Harvard Business School. Mr. Lund, a certified public accountant, graduated from University of North Texas and received his Master of Business Administration from the Kellogg School of Management of Northwestern University. Mr. Lund is actively involved in the NACD, Financial Executive Institute, American Institute of Certified Public Accountants and the Texas Society of Certified Public Accountants. Our board believes that Mr. Lund’s expertise in finance and accounting and his experience with corporate transactions and publicly listed companies make him well-suited to serve as a director.

Basic Compensation